May 5
|
Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?
|
May 1
|
Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company”
|
May 1
|
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
|
May 1
|
Top Dividend Stocks To Consider In May 2025
|
Apr 30
|
Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?
|
Apr 30
|
Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential
|
Apr 30
|
Construction begins on MSD’s $1bn biologics centre in Delaware, US
|
Apr 29
|
How To Put $100 In Your Retirement Fund Each Month With Merck Stock
|
Apr 29
|
Pfizer offers 'longer-term' opportunity amid tariff uncertainty
|
Apr 29
|
Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025?
|
Apr 29
|
Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
|
Apr 29
|
Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug
|
Feb 17
|
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
|
Feb 15
|
Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
|
Feb 13
|
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
|
Feb 13
|
Merck & Co., Inc. (MRK): A Bull Case Theory
|
Feb 13
|
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
|
Feb 12
|
Why Merck & Co., Inc. (MRK) is Declining
|
Feb 11
|
Jim Cramer on Merck & Co., Inc. (MRK): ‘Drug Stocks Are Really Getting Hurt’
|
Feb 11
|
Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant trea...
|